Skip to content 
EQL Pharma
Visionary Leadership by Axel Schörling
At the helm of EQL Pharma is Axel Schörling, a leader who blends engineering precision with financial acumen. His leadership philosophy centers on engagement, empowerment, and transparency, hallmarks of the Northern European management style. Rather than confining strategic insights to top executives, Axel ensures that the entire organization understands the company’s direction—creating a culture where employees feel ownership and accountability.
A Purpose-Driven Pharmaceutical Model
EQL Pharma operates with a clear mission: to deliver high-quality, cost-efficient medicines to pharmacies and hospitals. Its focus on niche generic drugs sets it apart in the pharmaceutical landscape.
Unlike widely competitive generics markets, niche segments often have limited suppliers. This creates two major challenges:
- Higher drug prices due to limited competition
- Risk of supply shortages affecting patient access
EQL Pharma addresses both by:
- Entering niche markets to drive prices down further
- Ensuring reliable supply chains, so critical medicines reach patients consistently
This dual impact not only benefits patients but also reduces the financial burden on healthcare systems and taxpayers.
A Standout Product: Mellozzan
One of the company’s most notable offerings is Mellozzan, a melatonin-based treatment designed for children with ADHD suffering from insomnia.
Work Culture: Transparency Meets Action
EQL Pharma’s internal culture is defined by a simple yet powerful philosophy:
“We roll up our sleeves and get things done.”
Instead of overanalyzing, the company prioritizes execution with accountability. Key cultural pillars include:
- Transparency: Everyone understands goals and progress
- Empowerment: Employees make decisions aligned with strategy
- Quality-first mindset: No compromise on safety or effectiveness
This creates a highly motivated workforce where innovation thrives organically.
Innovation Through Smart Business Models
While many pharmaceutical companies focus heavily on technological breakthroughs, EQL Pharma emphasizes commercial innovation:
- Identifying successful models in global markets
- Adapting and integrating them into Nordic healthcare systems
- Continuously refining pricing and distribution strategies
This approach allows the company to stay competitive while maintaining efficiency and scalability.
Balancing Leadership and Well-being
Despite the demanding nature of his role, Axel Schörling emphasizes the importance of work-life balance:
- Regular physical exercise
- Strong focus on sleep and mental well-being
- Keeping weekends largely work-free
This balanced approach reflects a modern leadership mindset—recognizing that sustainable performance comes from both professional dedication and personal well-being.
Future Outlook: Scaling Impact Across Healthcare
EQL Pharma’s future is rooted in growth with purpose:
- Expanding its portfolio of niche generics
- Strengthening its presence across the Nordic region
- Continuing to reduce healthcare costs without compromising quality
With a driven leadership team and a clear strategic vision, the company is poised to become a major force in affordable, high-quality pharmaceuticals.
Final Thought
EQL Pharma isn’t just another pharmaceutical company—it represents a smart, ethical, and sustainable approach to healthcare. By combining cost efficiency, supply reliability, and patient-centric innovation, it is redefining how medicines can serve both individuals and society at large.
